SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-008741
Filing Date
2013-08-29
Accepted
2013-08-29 09:49:38
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a2216468z10-k.htm 10-K 1178597
2 EX-23 a2216468zex-23.htm EX-23 3819
3 EX-31.1 a2216468zex-31_1.htm EX-31.1 7968
4 EX-31.2 a2216468zex-31_2.htm EX-31.2 7763
5 EX-32 a2216468zex-32.htm EX-32 4815
12 G461415.JPG g461415.jpg GRAPHIC 44716
  Complete submission text file 0001047469-13-008741.txt   13390685

Data Files

Seq Description Document Type Size
6 EX-101.INS imgn-20130630.xml EX-101.INS 1111127
7 EX-101.SCH imgn-20130630.xsd EX-101.SCH 67364
8 EX-101.CAL imgn-20130630_cal.xml EX-101.CAL 74319
9 EX-101.LAB imgn-20130630_lab.xml EX-101.LAB 990191
10 EX-101.PRE imgn-20130630_pre.xml EX-101.PRE 560823
11 EX-101.DEF imgn-20130630_def.xml EX-101.DEF 354874
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-17999 | Film No.: 131067484
SIC: 2834 Pharmaceutical Preparations